ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer.

Takeshi Shimamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.